首页> 外文期刊>Nucleic Acids Research >Human vault-associated non-coding RNAs bind to mitoxantrone, a chemotherapeutic compound.
【24h】

Human vault-associated non-coding RNAs bind to mitoxantrone, a chemotherapeutic compound.

机译:人与金库相关的非编码RNA与米托蒽醌(一种化学治疗化合物)结合。

获取原文
获取原文并翻译 | 示例
           

摘要

Human vaults are the largest cytoplasmic ribonucleoprotein and are overexpressed in cancer cells. Vaults reportedly function in the extrusion of xenobiotics from the nuclei of resistant cells, but the interactions of xenobiotics with the vault-associated proteins or non-coding RNAs have never been directly observed. In the present study, we show that vault RNAs (vRNAs), specifically the hvg-1 and hvg-2 RNAs, bind to a chemotherapeutic compound, mitoxantrone. Using an in-line probing assay (spontaneous transesterification of RNA linkages), we have identified the mitoxantrone binding region within the vRNAs. In addition, we analyzed the interactions between vRNAs and mitoxantrone in the cellular milieu, using an in vitro translation inhibition assay. Taken together, our results clearly suggest that vRNAs have the ability to bind certain chemotherapeutic compounds and these interactions may play an important role in vault function, by participating in the export of toxic compounds.
机译:人的穹ault是最大的胞质核糖核蛋白,在癌细胞中过表达。据报道,保藏库在抗药性细胞核中异种生物的挤出中起作用,但是从未直接观察到异种生物与保藏相关蛋白或非编码RNA的相互作用。在本研究中,我们显示了穹顶RNA(vRNA),特别是hvg-1和hvg-2 RNA与化学治疗化合物米托蒽醌结合。使用在线探测测定法(RNA连锁反应的自发酯交换反应),我们已经鉴定了vRNA内的米托蒽醌结合区。此外,我们使用体外翻译抑制试验分析了细胞环境中vRNA与米托蒽醌之间的相互作用。综上所述,我们的结果清楚地表明vRNA具有结合某些化学治疗化合物的能力,并且这些相互作用可能通过参与有毒化合物的出口而在库功能中发挥重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号